World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
60
Citations
27531
World Ranking
11669
National Ranking
5021

Overview

Faramarz Ismail-Beigi is affiliated with Case Western Reserve University in the United States. Their research spans primarily the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with significant contributions focusing on Endocrinology, Diabetes and Metabolism. Their academic work also intersects with Molecular Biology, Surgery, Cardiology and Cardiovascular Medicine, and Genetics as key subfields.

Their scholarly output encompasses topics that include diabetes treatment and management, metabolism related to diabetes and cancer, pancreatic function and diabetes, as well as diabetes management and research. Further areas of interest cover diabetes and associated disorders, liver disease diagnosis and treatment, and cardiovascular risks tied to diabetes and lipoproteins.

Frequent co-authors collaborating with Faramarz Ismail-Beigi include:

  • Michael A. Weiss
  • Mohammad E. Khamseh
  • Naji Younes
  • Ashok Balasubramanyam
  • Margaret Tiktin

Their work has been published extensively in various scholarly venues, notably:

  • UNC Libraries
  • Diabetes Care
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Diabetes
  • Advances in Therapy

Representative recent publications by Faramarz Ismail-Beigi include:

  • "Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes" (2020), Journal of Diabetes
  • "Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial" (2020), Advances in Therapy
  • "Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial" (2021), Diabetes Therapy
  • "Glucocorticoid-Induced Fatty Liver Disease" (2020), Diabetes Metabolic Syndrome and Obesity
  • "Intermittent fasting and 'metabolic switch': Effects on metabolic syndrome, prediabetes and type 2 diabetes" (2020), Diabetes Obesity and Metabolism

Best Publications

  • Effects of intensive glucose lowering in type 2 diabetes

    Hertzel C Gerstein;Michael E Miller;Robert P Byington

  • Effects of combination lipid therapy in type 2 diabetes mellitus.

    Henry N. Ginsberg;Laura C. Lovato;Lawrence A. Leiter;Peter Linz

  • Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

    Faramarz Ismail-Beigi;Timothy Craven;Mary Ann Banerji;Jan Basile

  • Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes

    Hertzel C. Gerstein;Michael E. Miller;Saul Genuth;Faramarz Ismail-Beigi

  • Regulation of glut1 mRNA by Hypoxia-inducible Factor-1 INTERACTION BETWEEN H-ras AND HYPOXIA

    Changhu Chen;Nabendu Pore;Alireza Behrooz;Faramarz Ismail-Beigi

  • Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials

    Faramarz Ismail-Beigi;Etie Moghissi;Margaret Tiktin;Irl B. Hirsch

  • DECREASED ABSORPTION OF CALCIUM, MAGNESIUM, ZINC AND PHOSPHORUS BY HUMANS DUE TO INCREASED FIBER AND PHOSPHORUS CONSUMPTION AS WHEAT BREAD

    John G. Reinhold;Bahram Faradji;Parichehr Abadi;Faramarz Ismail-Beigi

  • Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis

    Steven G. Coca;Faramarz Ismail-Beigi;Nowreen Haq;Harlan M. Krumholz

  • Mechanism of thyroid calorigenesis: role of active sodium transport.

    Faramarz Ismail-Beigi;Isidore S. Edelman

  • Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

    Hertzel C Gerstein;Matthew C Riddle;David M Kendall;Robert M Cohen

  • Regulation of glucose transport by hypoxia.

    Jin-Zhong Zhang;Alireza Behrooz;Faramarz Ismail-Beigi

  • Dual control of glut1 glucose transporter gene expression by hypoxia and by inhibition of oxidative phosphorylation.

    Alireza Behrooz;Faramarz Ismail-Beigi

  • Glycemic Management of Type 2 Diabetes Mellitus

    Faramarz Ismail-Beigi

  • Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport.

    Wafa Abbud;Sue Habinowski;Jin Zhong Zhang;Julie Kendrew

  • A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea.

    Tanya G Weinstock;Xuelei Wang;Michael Rueschman;Faramarz Ismail-Beigi

  • Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial.

    Hertzel C Gerstein;Michael E Miller;Faramarz Ismail-Beigi;Joe Largay

  • Protective hinge in insulin opens to enable its receptor engagement.

    John G. Menting;Yanwu Yang;Shu Jin Chan;Nelson B. Phillips

  • Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes.

    Marshall B. Elam;Henry N. Ginsberg;Laura C. Lovato;Marshall Corson

  • Overexpression of stomatin depresses GLUT-1 glucose transporter activity

    Jin Zhong Zhang;Wafa Abbud;Rainer Prohaska;Faramarz Ismail-Beigi

  • Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes.

    Aman Rajpal;Leili Rahimi;Faramarz Ismail-Beigi;Faramarz Ismail-Beigi

Frequent Co-Authors

Michael A. Weiss
Michael A. Weiss Case Western Reserve University
Hertzel C. Gerstein
Hertzel C. Gerstein McMaster University
Michael C. Lawrence
Michael C. Lawrence Walter and Eliza Hall Institute of Medical Research
John B. Buse
John B. Buse University of North Carolina at Chapel Hill
Robert M. Cohen
Robert M. Cohen University of Cincinnati Medical Center
Silvio E. Inzucchi
Silvio E. Inzucchi Yale University
Patrick J. O'Connor
Patrick J. O'Connor HealthPartners
William C. Cushman
William C. Cushman University of Tennessee Health Science Center
Richard H. Grimm
Richard H. Grimm University of Minnesota
Steven E. Kahn
Steven E. Kahn University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry can open the door to varied healthcare careers, including roles in health information management and medical coding. Many students consider an him degree to expand their career options. This qualification prepares you for the growing demand in managing medical records, data, and information systems in healthcare settings.

Medical coding is another popular field, offering flexibility and competitive salaries. If you’re curious about earning potential, learn more about medical.coder salary and how this role can align with your science background.

It’s also worth understanding cpc vs ccs certifications, both key credentials for medical coding professionals. Each has different requirements and career impacts.

Considering the job market? Read about is medical billing and coding in demand to help gauge the career outlook. With the right online degree and certification, these growing healthcare pathways may be an excellent fit for Biology and Biochemistry graduates.

Best Scientists Citing Faramarz Ismail-Beigi

Trending Scientists